>
Chinese freighter halves EU delivery time on maiden Arctic voyage to UK
Alex Jones Warns of the Globalist Death Cult Fueling the Next Civil War and Rise of the Antichrist
Is Donald Trump Intent Upon Imposing Martial Law in America?
Must-See Report! NATO Claims Putin Preparing To Attack Europe As Russia Enters 'Phase Zero'
SEMI-NEWS/SEMI-SATIRE: October 12, 2025 Edition
Stem Cell Breakthrough for People with Parkinson's
Linux Will Work For You. Time to Dump Windows 10. And Don't Bother with Windows 11
XAI Using $18 Billion to Get 300,000 More Nvidia B200 Chips
Immortal Monkeys? Not Quite, But Scientists Just Reversed Aging With 'Super' Stem Cells
ICE To Buy Tool That Tracks Locations Of Hundreds Of Millions Of Phones Every Day
Yixiang 16kWh Battery For $1,920!? New Design!
Find a COMPATIBLE Linux Computer for $200+: Roadmap to Linux. Part 1
Bionic hand with NO brain implants?!
Nano-cubosome eyedrops target macular degeneration without needles
Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.